Becton Dickinson & Co (BDX) stock
BDXNYSESurgical & Medical Instruments & ApparatusFiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026Score 13/3017% above fair value
$215.71+1.19 (+0.55%)
Close on Nov 12, 2026Market cap $58.76BP/E 65.2Yield 1.93%
Becton Dickinson price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Becton Dickinson's price to sales ratio was 2.6× on Nov 10, 2026, against 2.6× a year earlier. Over the last 5 years it ranged from 1.8× to 4.2×, with a median of 3.5×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 10, 2026 | 2.6× | +0.0 |
| 2025 | Dec 31, 2025 | 2.6× | −0.7 |
| 2024 | Dec 31, 2024 | 3.3× | −0.4 |
| 2023 | Dec 29, 2023 | 3.6× | −0.2 |
| 2022 | Dec 30, 2022 | 3.9× | +0.0 |
| 2021 | Dec 31, 2021 | 3.8× | −0.6 |
| 2020 | Dec 31, 2020 | 4.4× | +0.1 |
| 2019 | Dec 31, 2019 | 4.3× | +0.6 |
| 2018 | Dec 31, 2018 | 3.7× | −0.2 |
| 2017 | Dec 29, 2017 | 4.0× | +1.1 |
| 2016 | Dec 30, 2016 | 2.9× | −0.2 |
| 2015 | Dec 31, 2015 | 3.1× | −0.1 |
| 2014 | Dec 31, 2014 | 3.3× | +0.5 |
| 2013 | Dec 31, 2013 | 2.7× | +0.6 |
| 2012 | Dec 31, 2012 | 2.1× | −0.1 |
| 2011 | Dec 30, 2011 | 2.2× | −0.6 |
| 2010 | Dec 31, 2010 | 2.8× | +0.1 |
| 2009 | Dec 31, 2009 | 2.8× | – |
See a number that looks wrong?